ES8605771A1 - Procedimiento para preparar un polipeptido - Google Patents

Procedimiento para preparar un polipeptido

Info

Publication number
ES8605771A1
ES8605771A1 ES542310A ES542310A ES8605771A1 ES 8605771 A1 ES8605771 A1 ES 8605771A1 ES 542310 A ES542310 A ES 542310A ES 542310 A ES542310 A ES 542310A ES 8605771 A1 ES8605771 A1 ES 8605771A1
Authority
ES
Spain
Prior art keywords
formula
preparation
group
separation
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542310A
Other languages
English (en)
Spanish (es)
Other versions
ES542310A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES542310A0 publication Critical patent/ES542310A0/es
Publication of ES8605771A1 publication Critical patent/ES8605771A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES542310A 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido Expired ES8605771A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3414593 1984-04-18
DE19843438296 DE3438296A1 (de) 1984-04-18 1984-10-19 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (2)

Publication Number Publication Date
ES542310A0 ES542310A0 (es) 1985-12-16
ES8605771A1 true ES8605771A1 (es) 1985-12-16

Family

ID=25820510

Family Applications (3)

Application Number Title Priority Date Filing Date
ES542310A Expired ES8605771A1 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido
ES542309A Granted ES542309A0 (es) 1984-04-18 1985-04-16 Procedimiento para obtener un polipeptido purificado
ES542311A Granted ES542311A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES542309A Granted ES542309A0 (es) 1984-04-18 1985-04-16 Procedimiento para obtener un polipeptido purificado
ES542311A Granted ES542311A0 (es) 1984-04-18 1985-04-16 Procedimiento para preparar un polipeptido

Country Status (18)

Country Link
US (1) US4668662A (enExample)
EP (1) EP0158986B1 (enExample)
JP (1) JP2552263B2 (enExample)
KR (1) KR930000054B1 (enExample)
AR (1) AR242800A1 (enExample)
AU (1) AU580295B2 (enExample)
CA (1) CA1271298A (enExample)
DE (2) DE3438296A1 (enExample)
DK (1) DK171824B1 (enExample)
ES (3) ES8605771A1 (enExample)
FI (1) FI851521L (enExample)
GR (1) GR850942B (enExample)
HU (1) HU198085B (enExample)
IE (1) IE60581B1 (enExample)
IL (1) IL74948A (enExample)
NO (1) NO851535L (enExample)
PT (1) PT80301B (enExample)
ZA (1) ZA852854B (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3583361D1 (de) * 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE58903988D1 (de) * 1985-04-11 1993-05-13 Hoechst Ag Hirudin-derivat.
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US4971953A (en) * 1988-05-10 1990-11-20 Merrell Dow Pharmaceuticals Anticoagulant peptide alcohols
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
EP0416035B1 (en) * 1988-05-27 1994-12-07 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
ES2052062T3 (es) * 1988-06-11 1994-07-01 Ciba Geigy Ag Nuevos polipeptidos con actividad anticoagulante.
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
JPH07504152A (ja) * 1990-02-08 1995-05-11 マゲイニン　ファーマスーティカルズ，　インコーポレーテッド 生物活性ペプチドおよび標的細胞、ウイルス、あるいはウイルス感染細胞の成長を抑制する方法
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
AU641215B2 (en) * 1990-02-13 1993-09-16 Merrell Dow Pharmaceuticals Inc. Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
JPH05507273A (ja) * 1990-05-14 1993-10-21 マゲイニン　サイエンセズ　インコーポレーテッド Ｄアミノ酸残基を有する生物活性ペプチドの組成物およびそれによる治療方法
EP0559647A1 (en) * 1990-06-27 1993-09-15 Magainin Pharmaceuticals Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
JP3111075B2 (ja) * 1990-07-24 2000-11-20 メレルダウファーマスーティカルズ インコーポレイテッド 抗凝固ペプチド
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US6514730B1 (en) * 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
CA2120337A1 (en) * 1991-10-16 1993-04-17 Michael A. Zasloff Composition and treatment with biologically active peptides and antibiotic
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
NZ268159A (en) * 1993-06-11 1997-03-24 Merrell Pharma Inc Anticoagulant and antiplatelet peptides and their use
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) * 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) * 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE69625623T2 (de) 1996-01-31 2003-11-06 Sumitomo Bakelite Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
CN101095697A (zh) * 2006-06-28 2008-01-02 李振国 水蛭和/或地龙分子量5800道尔顿以下的提取物
US9056118B2 (en) * 2007-06-26 2015-06-16 Mudanjiang Youbo Pharmaceutical Co., Ltd. Extract for preventing of treating thrombotic diseases
US20110220575A1 (en) * 2008-11-19 2011-09-15 Nandu Deorkar New chromatographic media based on phenoxy alkyl and alkoxy-or phenoxy-phenyl alkyl ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3586333T2 (de) * 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens

Also Published As

Publication number Publication date
ES8605770A1 (es) 1985-12-16
PT80301B (de) 1987-02-10
NO851535L (no) 1985-10-21
CA1271298A (en) 1990-07-03
ES542309A0 (es) 1985-12-16
FI851521A7 (fi) 1985-10-19
IE60581B1 (en) 1994-07-27
ES8605772A1 (es) 1985-12-16
ES542311A0 (es) 1985-12-16
ES542310A0 (es) 1985-12-16
DK173985A (da) 1985-10-19
DK173985D0 (da) 1985-04-17
EP0158986A3 (en) 1988-09-21
DK171824B1 (da) 1997-06-23
JP2552263B2 (ja) 1996-11-06
KR850007801A (ko) 1985-12-09
EP0158986B1 (de) 1993-09-15
PT80301A (de) 1985-05-01
KR930000054B1 (ko) 1993-01-06
HU198085B (en) 1989-07-28
EP0158986A2 (de) 1985-10-23
HUT37806A (en) 1986-02-28
ZA852854B (en) 1985-11-27
AU580295B2 (en) 1989-01-12
FI851521A0 (fi) 1985-04-16
AR242800A1 (es) 1993-05-31
JPS60233098A (ja) 1985-11-19
IL74948A (en) 1989-09-10
IE850983L (en) 1985-10-18
US4668662A (en) 1987-05-26
DE3587576D1 (de) 1993-10-21
DE3438296A1 (de) 1985-11-07
AU4136485A (en) 1985-10-24
GR850942B (enExample) 1985-11-25
IL74948A0 (en) 1985-08-30
FI851521L (fi) 1985-10-19

Similar Documents

Publication Publication Date Title
ES8600216A1 (es) Un procedimiento para preparar octapeptidos lineales
ES8601108A1 (es) Procedimiento para la obtencion de eglinas b o c modificadas
ES2137182T3 (es) Derivados recombinantes del factor viii humano.
ES8401753A1 (es) Un procedimiento para la preparacion de un peptido inhibidor de la renina.
DK0642581T3 (da) Clostridium perfringens-vacciner
ES2169269T3 (es) Proceso para la preparacion de o-acetilserina, l-cisteina y productos afines a l-cisteina.
ES8701196A1 (es) Un procedimiento para la preparacion de dipeptidos derivados de tiazolina.
ES8205755A1 (es) Procedimiento para la preparacion de nonapeptidos y decapep-tidos analogos a lhrh,utiles como antagonistas de lhrh
GB8700204D0 (en) Pancreatic secretory trypsin inhibitor & variants
ES8606400A1 (es) Procedimiento para preparar peptidos
ES2032888T3 (es) Productos conservados para la limpieza del cabello y el cuerpo y utilizacion de una combinacion de sustancias conservantes.
ES8103027A1 (es) Un procedimiento para la preparacion de un polipeptido
ES2133295T3 (es) Peptidos ciclicos y su uso.
ES8407012A1 (es) Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.
ES8103026A1 (es) Un procedimiento para la preparacion de un peptido
ES8701785A1 (es) Un procedimiento para preparar un peptido ciclico basico conactividad antagonista de v1-vasopresina y oxitocina
ES2061759T3 (es) Amidas de acidos ciclometilen-1,2-dicarboxilicos con actividad terapeutica, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
CO5640064A2 (es) Citomodilacion de peptidos para tratar cistitis intersticial
ES2062282T3 (es) Proceso de racemizacion de esteres del acido carboxilico opticamente activos.
AR241800A1 (es) Procedimiento para preparar compuestos de eglina y procedimiento para obtener preparados farmaceuticos que incluyan a dichos compuestos de eglina como agente activo.
Martinage et al. Primary structure of histone H2A from gonads of the starfish Asterias rubens
ES8201954A1 (es) Un metodo para la preparacion de derivados del acido prope- noico.
ES8407011A1 (es) Un procedimiento para la preparacion de un derivado de un peptido ciclico a-21978c.
ES504996A0 (es) Un procedimiento para aislar un polipeptido purificado
AR018532A1 (es) Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506